Found 8 matching trials
A Combination Therapy In Patients With Social Anxiety Disorder
PHASE2The purpose of this study is to assess the efficacy, safety and tolerabilit...
Location
GSK Investigational Site
A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia
PHASE2Patients with Primary Insomnia will be treated with GW597599 and GR205171 t...
Location
GSK Investigational Site
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients
PHASE2The purpose of this study is to determine the effectiveness of this medicat...
Location
GSK Investigational Site
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
PHASE2This six-arm study is being conducted to measure the effect of a combinatio...
Location
GSK Investigational Site
Vestipitant 28-day Tolerance Study
PHASE2This study is a 28-day polysomnographic and subjective assessment of oral V...
Location
GSK Investigational Site
A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
PHASE2This study will evaluate single IV doses of Vestipitant (GW597599) compared...
Location
Helen Keller Hospital
Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
PHASE2Tinnitus associated to hearing loss is a high prevalent audiologic disorder...
Location
GSK Investigational Site
Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)
PHASE1The purpose of this study is to describe the safety and tolerability and ph...
Location
Investigational Site